Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer

Author:

Minicozzi Pamela1ORCID,Van Eycken Liesbet2,Molinie Florence34,Innos Kaire5ORCID,Guevara Marcela67,Marcos-Gragera Rafael78,Castro Clara910,Rapiti Elisabetta11,Katalinic Alexander12,Torrella Ana13,Žagar Tina14,Bielska-Lasota Magdalena15,Giorgi Rossi Paolo16,Larrañaga Nerea717,Bastos Joana1018,Sánchez Maria José71920,Sant Milena1,

Affiliation:

1. Analytical Epidemiology and Health Impact Unit, Research Department; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano; Milan Italy

2. Research Department; Belgian Cancer Registry; Brussels Belgium

3. Loire-Atlantique/Vendée Cancer Registry; Nantes France

4. SIRIC-ILIAD, CHU Nantes; Nantes France

5. Department of Epidemiology and Biostatistics; National Institute for Health Development; Tallinn Estonia

6. Navarra Cancer Registry, Public Health Institute of Navarra, IDISNA; Pamplona Spain

7. Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP); Madrid Spain

8. Epidemiology Unit and Girona Cancer Registry, Department of Health; Catalan Institute of Oncology (ICO); Girona Spain

9. Department of Epidemiology; Portuguese Oncology Institute of Porto (IPO Porto); Porto Portugal

10. EpiUnit, Institute of Public Health, University of Porto; Porto Portugal

11. Geneva Cancer Registry, Global Health Institute, University of Geneva; Geneva Switzerland

12. University of Lübeck, Institute for Social Medicine and Epidemiology; Lübeck Germany

13. Castellón Cancer Registry, Epidemiology Unit; Public Health Department; Castellón Spain

14. Epidemiology and Cancer Registry; Institute of Oncology Ljubljana; Ljubljana Slovenia

15. Department of Health Promotion and Prevention of Chronic Diseases; National Institute of Public Health (NIH); Warsaw Poland

16. Epidemiology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia; Reggio Emilia Italy

17. Public Health Department of Gipuzkoa; Donostia Spain

18. Portuguese Institute of Oncology Francisco Gentil (IPO Coimbra); Coimbra Portugal

19. Andalusian School of Public Health, Granada Cancer Registry; Granada Spain

20. Biomedical Research Institute of Granada (ibs. Granada); Granada Spain

Funder

Andalusian Department of Health

Spanish National Institute of Health, Carlos III

La Caixa Foundation

Instituto de Salud Carlos III

Ministry of Education, Science and Sport

Naradowe Centrum Badań i Rozwoju, Poland

Federal Ministry of Education and Research

Institut National Du Cancer

Research Foundation Flanders

Ministry of Health, Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3